W. Thorpe McKenzie 13D and 13G filings for XBiotech Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-23 4:33 pm Purchase | 2025-12-31 | 13G | XBIOTECH INC XBIT | W. Thorpe McKenzie | 3,006,259 9.760% | 18,750 (+0.63%) | Filing |
| 2025-01-27 2:39 pm Purchase | 2024-12-31 | 13G | XBIOTECH INC XBIT | W. Thorpe McKenzie | 2,987,509 9.710% | 16,250 (+0.55%) | Filing |
| 2024-02-07 12:01 pm Sale | 2023-12-31 | 13G | XBIOTECH INC XBIT | W. Thorpe McKenzie | 2,971,259 9.680% | -65,000 (-2.14%) | Filing |
| 2023-02-10 12:21 pm Purchase | 2022-12-31 | 13G | XBIOTECH INC XBIT | W. Thorpe McKenzie | 3,036,259 9.870% | 25,000 (+0.83%) | Filing |
| 2022-02-15 6:59 pm Sale | 2021-12-31 | 13G | XBIOTECH INC XBIT | W. Thorpe McKenzie | 3,011,259 9.810% | -1,931,080 (-39.07%) | Filing |